# Treatment of Rapid Onset Obesity, Hypoventilation, Hypothalamic Dysfunction, and Autonomic Dysregulation (ROHHAD )

> **NCT02441491** · NA · WITHDRAWN · sponsor: **Johns Hopkins University**

## Conditions studied

- ROHHAD Syndrome

## Interventions

- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT02441491
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-03
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-03-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Inadequate accrual
- **Last updated:** 2024-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02441491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02441491, "Treatment of Rapid Onset Obesity, Hypoventilation, Hypothalamic Dysfunction, and Autonomic Dysregulation (ROHHAD )". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02441491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*